Kiadis Pharma

Engaged in the clinical development and commercialization of cell-based immunotherapy products for treatment of blood cancer and blood disorders.

Launch date

1997

Employees

Market cap

Net debt

-

Enterprise valuation

$183m (Public information from Jul 2015)

Company register number 63512653

Amsterdam North Holland (HQ)

http://kiadis.com

https://twitter.com/kiadispharma https://www.facebook.com/kiadispharma https://www.linkedin.com/company/kiadis-pharma/

Deals in current and previous year:

CytoSen Therapeutics

Authorizing premium user...